Publicaciones en colaboración con investigadores/as de University of California, San Francisco (25)

2023

  1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

    British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294

2021

  1. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

    New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802

2017

  1. Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases

    Cancer Research, Vol. 77, Núm. 16, pp. 4365-4377

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. A global reference for human genetic variation

    Nature, Vol. 526, Núm. 7571, pp. 68-74

  2. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

    Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657

  3. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    Nature Genetics, Vol. 47, Núm. 2, pp. 164-171

2014

  1. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

    Nature Communications, Vol. 5

2012

  1. An integrated map of genetic variation from 1,092 human genomes

    Nature, Vol. 491, Núm. 7422, pp. 56-65

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

  3. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development

    Molecular Cancer Research, Vol. 10, Núm. 6, pp. 834-844

2011

  1. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility

    Genome Biology, Vol. 12, Núm. 1

2009

  1. Elevated cutaneous smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients

    Clinical Cancer Research, Vol. 15, Núm. 16, pp. 5101-5107

  2. Genetic architecture of mouse skin inflammation and tumour susceptibility

    Nature, Vol. 458, Núm. 7237, pp. 505-508

2008

  1. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease

    Catheterization and Cardiovascular Interventions, Vol. 72, Núm. 1, pp. 116-120

  2. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

    Journal of Thrombosis and Thrombolysis, Vol. 25, Núm. 2, pp. 214-218

  3. Human Proteinpedia enables sharing of human protein data [4]

    Nature Biotechnology

2007

  1. Crosstalk between Aurora-A and p53: Frequent Deletion or Downregulation of Aurora-A in Tumors from p53 Null Mice

    Cancer Cell, Vol. 11, Núm. 2, pp. 161-173

  2. Regulation of lamellipodial persistence, adhesion turnover, and motility in macrophages by focal adhesion kinase

    Journal of Cell Biology, Vol. 179, Núm. 6, pp. 1275-1287